HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+9.44%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.67B
AUM Growth
+$2.67B
(+22%)
Cap. Flow
+$275M
Cap. Flow
% of AUM
10.31%
Top 10 Holdings %
Top 10 Hldgs %
62.01%
Holding
53
New
15
Increased
10
Reduced
9
Closed
16
Top Buys
| 1 |
Danaher
DHR
|
$108M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$108M |
| 3 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$88.8M |
| 4 |
Cardinal Health
CAH
|
$84.5M |
| 5 |
Hologic
HOLX
|
$76.6M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$115M |
| 2 |
AET
Aetna Inc
AET
|
$102M |
| 3 |
Merck
MRK
|
$93.7M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$77.9M |
| 5 |
Align Technology
ALGN
|
$60.2M |
Sector Composition
| 1 | Healthcare | 93.1% |
| 2 | Financials | 5.12% |
| 3 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIVV
1
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $390M | 14.06% | 6,475,000 +1,475,000 | +30% | +$88.8M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $250M | 9.02% | 1,925,000 +525,000 | +38% | +$68.2M |
|
3
Labcorp
LH
$23.1B
| $212M | 7.65% | 1,375,000 +350,000 | +34% | +$53.9M |
|
4
Edwards Lifesciences
EW
$47.8B
| $142M | 5.12% | 1,200,000 -50,000 | -4% | -$5.91M |
|
|
AET
5
DELISTED
Aetna Inc
AET
| $137M | 4.93% | 900,000 -675,000 | -43% | -$102M |
|
|
6
Danaher
DHR
$147B
| $118M | 4.27% | 1,402,340 +1,284,160 | +1,087% | +$108M |
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $117M | 4.23% | 2,550,178 +1,325,178 | +108% | +$61M |
|
|
MNK
8
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $108M | 3.88% | +2,402,350 | New | +$108M |
|
9
Intuitive Surgical
ISRG
$170B
| $95.7M | 3.45% | 102,308 -47,692 | -32% | -$44.6M |
|
10
Pacira BioSciences
PCRX
$1.2B
| $85.6M | 3.09% | 1,793,799 +693,799 | +63% | +$33.1M |
|
|
11
Cardinal Health
CAH
$35.5B
| $84.5M | 3.05% | +1,084,396 | New | +$84.5M |
|
12
Vertex Pharmaceuticals
VRTX
$100B
| $78.4M | 2.83% | 608,426 -416,574 | -41% | -$53.7M |
|
|
13
Hologic
HOLX
$14.9B
| $76.6M | 2.76% | +1,688,060 | New | +$76.6M |
|
14
Haemonetics
HAE
$2.63B
| $73.2M | 2.64% | 1,854,872 +254,872 | +16% | +$10.1M |
|
15
Sarepta Therapeutics
SRPT
$1.78B
| $68.5M | 2.47% | 2,031,890 +481,890 | +31% | +$16.2M |
|
16
Zimmer Biomet
ZBH
$21B
| $65.2M | 2.35% | +507,430 | New | +$65.2M |
|
17
Humana
HUM
$36.5B
| $59.9M | 2.16% | 249,098 +124,098 | +99% | +$29.9M |
|
18
AbbVie
ABBV
$372B
| $58M | 2.09% | +799,430 | New | +$58M |
|
19
Pediatrix Medical
MD
$1.5B
| $56.9M | 2.05% | +942,730 | New | +$56.9M |
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $50.7M | 1.83% | +208,700 | New | +$50.7M |
|
21
Bristol-Myers Squibb
BMY
$96B
| $45.4M | 1.64% | 815,120 +365,120 | +81% | +$20.3M |
|
22
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $37.5M | 1.35% | +472,780 | New | +$37.5M |
|
|
CVRS
23
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $37.2M | 1.34% | 19,981,655 | – | – |
|
24
Centene
CNC
$14.3B
| $34.6M | 1.25% | +432,864 | New | +$34.6M |
|
|
WBA
25
DELISTED
Walgreens Boots Alliance
WBA
| $33.2M | 1.2% | +424,350 | New | +$33.2M |
|